Table 1 Demographics across control and CSC cohorts.

From: Sleep and mood in central serous chorioretinopathy

 

Controls

CSC

All Patients

All Patients

Chronic

Acute

N (male/female)

247 (69/178)

109 (70/39)

88 (57/31)

21 (13/8)

Age years (mean, SD)

52 (13)

54 (12)

56 (11)

49 (12)

BCVA

Mean, SD

N/A

0.060 (0.253)

0.0823 (0.266)

‒0.0280 (0.152)1

Missing

N/A

1

0

 

BMI (mean, SD)

27.0 (6.92)

26.2 (5.94)

26.2 (6.10)

25.7 (5.28)

Missing

10

3

1

1

Global PSQI

5.59 (3.24)

5.26 (3.37)

5.32 (3.60)

4.90 (2.02)

Sleep quality

1.081 (0.739)

1.08 (0.73)

1.09 (0.748)

1.05 (0.686)

Sleep latency

0.773 (0.719)

0.648 (0.674)

0.671 (0.690)

0.600 (0.598)

Sleep duration

0.709 (0.853)

0.704 (0.889)

0.739 (0.941)

0.500 (0.607)

Sleep efficiency

0.761 (1.01)

0.824 (0.994)

0.852 (1.034)

0.600 (0.754)

Sleep disturbance

1.33 (0.551)

1.21 (0.513)

1.23 (0.541)

1.15 (0.366)

Sleep medication

0.174 (0.617)

0.157 (0.614)

0.171 (0.665)

0.050 (0.224)

Daytime dysfunction

0.757 (0.753)

0.657 (0.787)

0.602 (0.796)

0.950 (0.686)

ESS

6.37 (4.21)

5.78 (3.91)

5.89 (3.98)

5.53 (3.55)

HADS

8.58 (6.04)

8.14 (5.20)

8.30 (5.37)

7.53 (4.39)

HADS-A

5.52 (3.61)

5.37 (3.42)

5.39 (3.52)

5.21 (2.97)

HADS-D

3.05 (3.03)

2.76 (2.63)

2.90 (2.70)

2.32 (2.34)

MEQ (chronotype)

60.4 (9.41)

62.3 (8.96)

62.4 (9.01)

62.7 (9.21)

MET (diurnal preference)

1.59 (0.983)

1.39 (0.979)

1.38 (0.975)

1.37 (1.06)

Physical function

84.7 (21.6)

90.1 (16.2)

88.9 (17.4)

95.0 (7.07)

Emotional wellbeing

76.6 (16.5)

77.7 (14.2)

79.00 (14.3)

72.00 (12.2)

Social functioning

88.1 (19.8)

90.1 (19.9)

89.9 (19.4)

89.5 (22.5)

Pain

80.5 (22.0)

83.8 (22.1)

84.0 (22.4)

83.6 (21.1)

General health

70.9 (19.7)

72.9(18.4)

72.2 (18.1)

76.3 (19.9)

  1. Here, other than for male/female, standard deviation (SD) is represented in brackets beside mean values. Best visual acuity denoted as “BCVA”.